PedAM
Pediatric Disease Annotations & Medicines
| Disease | ocular hypertension |
| Symptom | C0021888|intraocular pressure |
| Sentences | 11 |
| PubMedID- 23353557 | The biochemistry, clinical efficacy and side effects of four commercially available pgf2alpha analogues, currently used as first-line agents for reducing intraocular pressure in patients with glaucoma or ocular hypertension, are also discussed. |
| PubMedID- 22140308 | However, their intake, particularly that of coffee, has been suggested to increase intraocular pressure (iop) in patients with open angle glaucoma/ocular hypertension. |
| PubMedID- 21468349 | Medical treatment, laser trabeculoplasty, and surgery can be used to control intraocular pressure (iop) in patients with ocular hypertension (oht) and primary open-angle glaucoma (poag). |
| PubMedID- 22370470 | Purpose: to investigate the long-term effect of phacoemulsification on intraocular pressure (iop) in patients with ocular hypertension and open-angle glaucoma. |
| PubMedID- 19844722 | There are different laser systems for reducing the intraocular pressure of patients with glaucoma and ocular hypertension. |
| PubMedID- 23077405 | intraocular pressure of ocular hypertension model eyes. |
| PubMedID- 20164834 | A model-based meta-analysis of the effect of latanoprost chronotherapy on the circadian intraocular pressure of patients with glaucoma or ocular hypertension. |
| PubMedID- 23900094 | Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma. |
| PubMedID- 23429622 | Results: after surgery, 70 eyes (47.9%) had at least 1 period of ocular hypertension, with a mean intraocular pressure (iop) of 27.15+/-5.66 mm hg. |
| PubMedID- 21946548 | Purpose: to compare the daily versus the alternate day use of travoprost 0.004% in lowering the intraocular pressure (iop) in patients with ocular hypertension. |
| PubMedID- 21716127 | Purpose: to evaluate the effect of 6 weeks administration of beclomethasone nasal spray on intraocular pressure (iop) in patients with ocular hypertension or controlled primary open-angle glaucoma. |
Page: 1